NLCS (Singapore) Hosts Inaugural International MUN Conference Uniting Students from Its Global Family of Schools
SINGAPORE, April 15, 2026 /PRNewswire/ -- NLCS (Singapore) was excited to host its first-ever International Model United Nations (MUN) Conference at the end of February, welcoming students from across the NLCS family of schools, including London,...
Addepar Establishes Singapore as Asia-Pacific Hub
The move underscores Addepar's continued global expansion and long-term strategic investment in the region SINGAPORE, April 14, 2026 /PRNewswire/ -- Addepar, a global data and AI platform for investment professionals, today announced the opening of...
SST001, an α-syn PET tracer from Mabwell's incubated company SynuSight Biotech, received NMPA approval to initiate a clinical trial
SHANGHAI, April 15, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that 18F-FD4 (R&D code: SST001), an α-synuclein (α-syn) targeted PET tracer...
Nexon Asia Pacific joins the Microsoft Intelligent Security Association
SYDNEY, April 15, 2026 /PRNewswire/ -- Nexon Asia Pacific (Nexon), today announced it has become a member of the Microsoft Intelligent Security Association (MISA), an ecosystem of software development companies and security services partners that...
Heavy industry could grow global output while using up to 45% less energy by 2050
30-50% of costs for heavy industry come from energy consumption 25-45% reduction in energy use across aluminium, aviation, cement, plastics & chemicals, shipping and steel is achievable through energy productivity measures including longer...
Allianz Partners announces multi-year partnership with five Para athletes across the globe
Allianz Partners launches a long-term collaboration with five exceptional Para athletes as part of its "Connecting with Champions" program. The initiative reflects Allianz's commitment to inclusivity, community, and the transformative power of...
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed with TLX101-Tx (¹³¹I-iodofalan) in Telix's pivotal IPAX BrIGHT...
Telix Successfully Prices and Upsizes US$600 Million Convertible Bonds
MELBOURNE, Australia and Indianapolis, April 15, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) ("Telix") is pleased to announce that it has successfully priced and upsized its 1.50 per cent convertible notes due 2031 to...